naag activates a specific receptor, the metabotropic glutamate receptor type 3. it is synthesized enzymatically from its two precursors and catabolized by naag peptidases in the synapse. the inhibition of the latter enzymes has potentially important therapeutic effects in animal models of several neurologic conditions and disorders.